Treatment Options
Compare StartEnhance's featured offers
These pages are built around the two product decisions StartEnhance actually presents to visitors: compounded semaglutide and compounded tirzepatide. Each one connects the offer to pricing context, provider review, and trust information.
Adults researching compounded semaglutide because they want a lower-cost GLP-1 starting point and a clearer self-pay decision.
Explore StartEnhance's compounded semaglutide offer, including pricing expectations, provider review, and what self-pay buyers should understand before starting.
- Clearer framing around the homepage semaglutide offer from $133
- Useful for self-pay visitors comparing affordability before they click through
- Connects the medication-specific question to pricing, process, and trust pages
Adults comparing the more premium StartEnhance offer and wanting a clearer picture of the compounded tirzepatide pathway before they start.
Review StartEnhance's compounded tirzepatide offer, including who it may suit, how provider review works, and what self-pay buyers should understand before applying.
- Built around the homepage tirzepatide offer from $166
- Useful for visitors comparing tirzepatide specifically rather than browsing generic GLP-1 content
- Creates a tighter commercial page for the highest-intent medication-specific searches